Prilosec /00661201/


Combined with:

Enbrel

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 19.8%
Nausea 18.6%
Abdominal Pain Upper 14.0%
Crohn's Disease 14.0%
Irritable Bowel Syndrome 14.0%
Anxiety 4.7%
Panic Attack 4.7%
Contraception 2.3%
Dyspepsia 2.3%
Gait Disturbance 2.3%
Gastrooesophageal Reflux Disease 1.2%
Micturition Urgency 1.2%
Oesophageal Pain 1.2%
Withdrawal Syndrome 50.0%
Renal Failure Acute 25.0%
Flatulence 12.5%
Heart Rate Irregular 12.5%
Concomitant
Product Used For Unknown Indication 74.3%
Hepatitis C 3.7%
Rheumatoid Arthritis 3.5%
Pain 2.3%
Gastrooesophageal Reflux Disease 2.0%
Hypertension 1.9%
Drug Use For Unknown Indication 1.6%
Psoriatic Arthropathy 1.3%
Osteoporosis Postmenopausal 1.2%
Supplementation Therapy 1.2%
Type 2 Diabetes Mellitus 1.0%
Plasma Cell Myeloma 0.9%
Psoriasis 0.8%
Diabetes Mellitus 0.8%
Pulmonary Hypertension 0.7%
Nausea 0.7%
Non-small Cell Lung Cancer 0.5%
Prophylaxis 0.5%
Anxiety 0.5%
Bronchitis 0.5%
Drug Ineffective 11.9%
Vomiting 10.8%
Therapeutic Response Decreased 8.2%
Sinusitis 7.5%
Weight Decreased 7.1%
Nausea 6.0%
Death 4.9%
Injection Site Pain 4.9%
Malignant Neoplasm Progression 4.1%
Rash 4.1%
Injection Site Reaction 3.7%
Wrong Technique In Drug Usage Process 3.4%
Injection Site Swelling 3.0%
Nasopharyngitis 3.0%
Pain 3.0%
Pain In Extremity 3.0%
Tremor 3.0%
Urticaria 3.0%
Weight Increased 3.0%
Oedema Peripheral 2.6%

Drug Data